These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 8205522)

  • 1. A negative regulatory factor is missing in a human metastatic breast cancer cell line.
    Stover DM; Carey I; Garzon RJ; Zehner ZE
    Cancer Res; 1994 Jun; 54(12):3092-5. PubMed ID: 8205522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of vimentin gene transcription in human breast cancer cell lines.
    Sommers CL; Skerker JM; Chrysogelos SA; Bosseler M; Gelmann EP
    Cell Growth Differ; 1994 Aug; 5(8):839-46. PubMed ID: 7986748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vimentin promoter as a tool to analyze the early events of retinoic acid-induced differentiation of cultured embryonal carcinoma cells.
    Benazzouz A; Duprey P
    Differentiation; 1999 Nov; 65(3):171-80. PubMed ID: 10631814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of chicken vimentin gene expression by serum, phorbol ester, and growth factors: identification of a novel fibroblast growth factor-inducible element.
    Carey I; Zehner ZE
    Cell Growth Differ; 1995 Jul; 6(7):899-908. PubMed ID: 7547512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
    Singh J; Murata K; Itahana Y; Desprez PY
    Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines.
    Sommers CL; Heckford SE; Skerker JM; Worland P; Torri JA; Thompson EW; Byers SW; Gelmann EP
    Cancer Res; 1992 Oct; 52(19):5190-7. PubMed ID: 1382837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of and effector for metastasis-inducing DNAs from a human metastatic carcinoma cell line.
    Chen H; Ke Y; Oates AJ; Barraclough R; Rudland PS
    Oncogene; 1997 Apr; 14(13):1581-8. PubMed ID: 9129149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis.
    Urquidi V; Sloan D; Kawai K; Agarwal D; Woodman AC; Tarin D; Goodison S
    Clin Cancer Res; 2002 Jan; 8(1):61-74. PubMed ID: 11801541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the human SOX3 promoter: identification of transcription factors implicated in basal promoter activity.
    Kovacevic Grujicic N; Mojsin M; Krstic A; Stevanovic M
    Gene; 2005 Jan; 344():287-97. PubMed ID: 15656994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moesin expression is associated with the estrogen receptor-negative breast cancer phenotype.
    Carmeci C; Thompson DA; Kuang WW; Lightdale N; Furthmayr H; Weigel RJ
    Surgery; 1998 Aug; 124(2):211-7. PubMed ID: 9706140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stat3 enhances vimentin gene expression by binding to the antisilencer element and interacting with the repressor protein, ZBP-89.
    Wu Y; Diab I; Zhang X; Izmailova ES; Zehner ZE
    Oncogene; 2004 Jan; 23(1):168-78. PubMed ID: 14712222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complex regulation of the fibroblast growth factor-binding protein in MDA- MB-468 breast cancer cells by CCAAT/enhancer-binding protein beta.
    Kagan BL; Henke RT; Cabal-Manzano R; Stoica GE; Nguyen Q; Wellstein A; Riegel AT
    Cancer Res; 2003 Apr; 63(7):1696-705. PubMed ID: 12670924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The zinc finger repressor, ZBP-89, binds to the silencer element of the human vimentin gene and complexes with the transcriptional activator, Sp1.
    Wieczorek E; Lin Z; Perkins EB; Law DJ; Merchant JL; Zehner ZE
    J Biol Chem; 2000 Apr; 275(17):12879-88. PubMed ID: 10777586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
    Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
    J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential display of reticulocalbin in the highly invasive cell line, MDA-MB-435, versus the poorly invasive cell line, MCF-7.
    Liu Z; Brattain MG; Appert H
    Biochem Biophys Res Commun; 1997 Feb; 231(2):283-9. PubMed ID: 9070264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of MDR1 promoter activity in MCF-7, but not in multidrug resistant MCF-7/Adr, cells by cross-coupled NF-kappa B/p65 and c-Fos transcription factors and their interaction with the CAAT region.
    Ogretmen B; Safa AR
    Biochemistry; 1999 Feb; 38(7):2189-99. PubMed ID: 10026303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of the death-promoting gene bax-alpha which is downregulated in breast cancer restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice.
    Bargou RC; Wagener C; Bommert K; Mapara MY; Daniel PT; Arnold W; Dietel M; Guski H; Feller A; Royer HD; Dörken B
    J Clin Invest; 1996 Jun; 97(11):2651-9. PubMed ID: 8647960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.